Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-05 Purchase | 2023-06-05 9:52 pm | ImmunityBio Inc. | IBRX | BLASZYK MICHAEL D Director | 71,915 | $2.7536 | $198,023 | 265,582 (Indirect Direct) | View |
| 2023-06-02 Purchase | 2023-06-05 7:55 pm | ImmunityBio Inc. | IBRX | Brennan John Owen Director | 25,000 | $2.828 | $70,700 | 25,000 (Direct) | View |
| 2023-06-01 Purchase | 2023-06-05 7:54 pm | ImmunityBio Inc. | IBRX | Clark Wesley Director | 7,000 | $2.91 | $20,370 | 8,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-22 Option Award | 2024-02-26 4:43 pm | N/A N/A | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 204,877 | $0 | 204,877 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 4:41 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 54,634 | $0 | 54,634 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 4:40 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 546,341 | $0 | 546,341 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 4:38 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 2,048,780 | $0 | 2,048,780 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 4:36 pm | N/A N/A | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK See remarks 10% Owner | 1,536,584 | $0 | 1,536,584 (Direct) | View |
| 2024-02-05 Exercise | 2024-02-06 9:14 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 83,334 | $0 | 243,138 (Direct) | View |
| 2024-02-05 Tax Withholding | 2024-02-06 9:14 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 43,165 | $4.04 | 243,138 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 7:38 pm | N/A N/A | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 57,200 | $0 | 3,123,761 (Direct) | View |
| 2024-01-31 Tax Withholding | 2024-02-02 7:38 pm | N/A N/A | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 22,094 | $3.36 | 3,123,761 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 7:33 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 70,745 | $0 | 185,838 (Direct) | View |
| 2024-01-31 Tax Withholding | 2024-02-02 7:33 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 26,835 | $3.36 | 185,838 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 7:32 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 32,872 | $0 | 94,334 (Direct) | View |
| 2024-01-31 Tax Withholding | 2024-02-02 7:32 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 13,470 | $3.36 | 94,334 (Direct) | View |
| 2023-12-29 Other | 2024-01-03 9:53 pm | 2023-05-12 2025-12-31 | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Nant Capital LLC See remarks 10% Owner | 30,000,000 | $30,000,000 | 410,000,000 (Indirect) | View |
| 2023-12-29 Other | 2024-01-03 9:53 pm | 2023-12-29 2025-12-31 | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Nant Capital LLC See remarks 10% Owner | 380,000,000 | $380,000,000 | 410,000,000 (Indirect) | View |
| 2023-12-31 Exercise | 2024-01-03 9:41 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 30,397 | $0 | 248,324 (Direct) | View |
| 2023-12-31 Tax Withholding | 2024-01-03 9:41 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 10,511 | $5.02 | 248,324 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 9:40 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 34,483 | $0 | 323,666 (Direct) | View |
| 2023-12-31 Tax Withholding | 2024-01-03 9:40 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 17,096 | $5.02 | 323,666 (Direct) | View |
| 2023-12-15 Exercise | 2023-12-19 4:41 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 21,030 | $0 | 95,963 (Direct) | View |
| 2023-09-11 Other | 2023-09-13 9:07 pm | N/A N/A | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Cambridge Equities LP MP 13 Ventures LLC CALIFORNIA CAPITAL EQUITY LLC Nant Capital LLC See remarks 10% Owner | 209,291,936 | $1.29 | 765,043,486 (Indirect) | View |
| 2023-09-11 Other | 2023-09-13 9:07 pm | 2022-08-31 2025-09-30 | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Cambridge Equities LP MP 13 Ventures LLC CALIFORNIA CAPITAL EQUITY LLC Nant Capital LLC See remarks 10% Owner | 269,986,600 | $0 | 765,043,486 (Indirect) | View |
| 2023-09-01 Exercise | 2023-09-06 7:41 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 70,744 | $0 | 192,787 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-06 7:40 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 32,872 | $0 | 86,774 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-06 7:39 pm | N/A N/A | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 57,199 | $0 | 3,145,855 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-28 9:01 pm | N/A N/A | ImmunityBio Inc. | IBRX | Simon Barry J. Director | 114,399 | $0 | 114,399 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-28 9:00 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 65,744 | $0 | 65,744 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-28 8:58 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 141,489 | $0 | 141,489 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-16 5:45 pm | N/A N/A | ImmunityBio Inc. | IBRX | LAUER REGAN J Chief Accounting Officer | 21,030 | $0 | 63,091 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:30 pm | N/A 2033-06-13 | ImmunityBio Inc. | IBRX | Selecky Christobel Director | 158,263 | $0 | 158,263 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:29 pm | N/A 2033-06-13 | ImmunityBio Inc. | IBRX | MAXWELL LINDA Director | 158,263 | $0 | 158,263 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:28 pm | N/A 2033-06-13 | ImmunityBio Inc. | IBRX | Cohen Cheryl Director | 158,263 | $0 | 158,263 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:27 pm | N/A 2033-06-13 | ImmunityBio Inc. | IBRX | Clark Wesley Director | 158,263 | $0 | 158,263 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:25 pm | N/A 2033-06-13 | ImmunityBio Inc. | IBRX | Brennan John Owen Director | 158,263 | $0 | 158,263 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:24 pm | N/A 2033-06-13 | ImmunityBio Inc. | IBRX | BLASZYK MICHAEL D Director | 158,263 | $0 | 158,263 (Direct) | View |
Ownership(A) | 2023-03-01 8:43 pm | N/A N/A | ImmunityBio Inc. | IBRX | Clark Wesley Director | 0 | $0 | 1,000 (Direct) | View |
| 2023-02-05 Exercise | 2023-02-07 6:23 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 83,333 | $0 | 268,916 (Direct) | View |
| 2023-02-05 Tax Withholding | 2023-02-07 6:23 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 42,192 | $4.33 | 268,916 (Direct) | View |
| 2022-12-31 Exercise | 2023-01-04 9:49 pm | N/A N/A | ImmunityBio Inc. | IBRX | Sachs David C. Chief Financial Officer | 7,598 | $0 | 188,091 (Direct) | View |
| 2022-12-31 Exercise | 2023-01-04 9:48 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 8,620 | $0 | 299,621 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 9:48 pm | N/A N/A | ImmunityBio Inc. | IBRX | Adcock Richard CEO & President | 4,273 | $5.07 | 299,621 (Direct) | View |
| 2022-12-12 Conversion | 2022-12-14 4:23 pm | N/A N/A | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Cambridge Equities LP MP 13 Ventures LLC CALIFORNIA CAPITAL EQUITY LLC See remarks 10% Owner | 9,986,920 | $5.67 | 323,244,565 (Indirect) | View |
| 2022-12-12 Conversion | 2022-12-14 4:23 pm | 2022-08-31 2025-09-30 | ImmunityBio Inc. | IBRX | SOON-SHIONG PATRICK Cambridge Equities LP MP 13 Ventures LLC CALIFORNIA CAPITAL EQUITY LLC See remarks 10% Owner | 56,625,842 | $0 | 323,244,565 (Indirect) | View |
| 2022-06-14 Option Award | 2022-06-15 9:26 pm | N/A 2032-06-14 | ImmunityBio Inc. | IBRX | Selecky Christobel Director | 167,937 | $0 | 167,937 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 9:24 pm | N/A 2032-06-14 | ImmunityBio Inc. | IBRX | MAXWELL LINDA Director | 167,937 | $0 | 167,937 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-15 9:22 pm | N/A 2032-06-14 | ImmunityBio Inc. | IBRX | Cohen Cheryl Director | 167,937 | $0 | 167,937 (Direct) | View |